| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.09 | 0.1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |